Opportunity Information: Apply for PA 18 148
The National Institutes of Health (NIH) grant opportunity "Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional)" (Funding Opportunity Number: PA 18-148) supports research aimed at strengthening how care is coordinated for people enrolled in hospice and for the family members and friends who care for them. The core goal is to reduce harmful or distressing outcomes that can happen when patients experience unwanted or poorly managed transitions near the end of life, such as transfers between settings or disruptions in who is providing care. At the same time, the announcement encourages studies that identify and test practical ways to improve continuity of care, communication, and coordination so that both patients and families have better experiences and outcomes during hospice.
The FOA is focused on hospice patients and family caregivers across every setting where hospice services are delivered. That includes care provided in a patients own home, a relatives home, hospice inpatient facilities, assisted living facilities, short- or long-term care facilities (including nursing homes), and hospitals. The emphasis on multiple settings reflects a real-world problem in end-of-life care: hospice patients may move between locations or rely on multiple clinicians, agencies, and facilities, and those handoffs can create confusion, duplicated services, gaps in symptom management, and emotional strain for families. Research responsive to this announcement would typically look at how these transitions occur, why they become unwanted, how coordination breaks down, and what systems or interventions can prevent unnecessary disruption while still ensuring appropriate care.
Because the mechanism is an R01, the opportunity is designed for more substantial, well-developed research projects rather than small pilot efforts. The "clinical trial optional" designation means applicants can propose either observational or interventional research, and they may include a clinical trial if it fits the aims, but a trial is not required. Projects may address outcomes for individuals (for example, symptom burden, distress, quality of life, care goal alignment, or hospitalization patterns) and outcomes for family caregivers (for example, caregiving burden, preparedness, communication experiences, satisfaction with care, or bereavement-related outcomes). In general, the announcement is centered on measurable improvements that come from better continuity and coordination, not simply describing problems.
Eligible applicants are broad, spanning public and private organizations. Eligible entities include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, tribal governments other than federally recognized, and non-U.S. (foreign) organizations. This wide eligibility is intended to encourage research teams that reflect the diversity of hospice care environments and patient populations, including communities that are often underserved or disproportionately affected by barriers in serious illness care.
From an administrative standpoint, this is a discretionary grant in the NIH system, categorized under education and health, with CFDA number 93.361. The original posting date for the opportunity was November 7, 2017, and the original closing date listed is January 7, 2020 (noting that NIH funding opportunities sometimes have multiple receipt dates or may be reissued over time, but the provided source data lists that closing date). An award ceiling is not specified in the provided details, and expected awards are not listed, which is common for many NIH program announcements where budgets depend on the scope, institute priorities, and availability of funds.
Overall, the opportunity is best understood as NIH seeking stronger evidence on how to prevent avoidable, unwanted end-of-life transitions and how to build hospice care processes that remain consistent, coordinated, and person- and family-centered regardless of where the patient is located. The intended impact is not only better clinical and quality-of-life outcomes for hospice patients, but also reduced stress and improved support for family caregivers who often shoulder much of the practical and emotional work during the hospice period.Apply for PA 18 148
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.361.
- This funding opportunity was created on 2017-11-07.
- Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this NIH funding opportunity?
The funding opportunity is titled "Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional)" with Funding Opportunity Number PA 18-148.
What is the main purpose of this grant opportunity?
The purpose is to support research that strengthens continuity and coordination of hospice care for enrolled patients and for the family members and friends who provide care. The central goal is to reduce harmful or distressing outcomes that can occur when patients experience unwanted or poorly managed transitions near the end of life, such as transfers between settings or disruptions in who is providing care.
What kinds of problems is NIH trying to address through this FOA?
This FOA is aimed at real-world issues that can arise when hospice patients move between locations or rely on multiple clinicians, agencies, or facilities. These handoffs can create confusion, duplicated services, gaps in symptom management, and emotional strain for families. The FOA encourages research that examines how and why coordination breaks down and tests practical ways to improve it.
Is this opportunity focused on hospice patients only, or also on caregivers?
It is focused on both. The FOA supports projects that improve outcomes for hospice patients as well as outcomes for family caregivers (including family members and friends who provide care).
What settings are included in the scope of this hospice research?
The FOA includes every setting where hospice services are delivered, including a patient's own home, a relative's home, hospice inpatient facilities, assisted living facilities, short- or long-term care facilities (including nursing homes), and hospitals.
Why does the FOA emphasize multiple hospice care settings?
Because hospice care often involves movement between locations and coordination among multiple providers and organizations. The FOA reflects the reality that transitions and handoffs can introduce risks, disruptions, and distress, and it seeks evidence-based approaches that support consistent, coordinated, person- and family-centered care regardless of setting.
What does "continuity and coordination of care" mean in the context of this FOA?
Within this FOA, continuity and coordination refer to maintaining consistent, well-communicated, and well-managed hospice care across people, organizations, and settings. This includes improving communication, preventing unnecessary disruption, and ensuring care remains aligned with patient goals even when transitions occur.
Does NIH expect projects to only describe the problem, or to test improvements?
The FOA is centered on measurable improvements that come from better continuity and coordination, not simply describing problems. Studies that identify and test practical ways to improve continuity, communication, and coordination are encouraged.
What is the grant mechanism for this opportunity?
The mechanism is an NIH R01, which is intended for more substantial, well-developed research projects rather than small pilot efforts.
What does "Clinical Trial Optional" mean for PA 18-148?
"Clinical Trial Optional" means applicants may propose either observational or interventional research, and they may include a clinical trial if it fits the project aims, but a clinical trial is not required.
What types of outcomes for hospice patients may be addressed under this FOA?
Examples of individual patient outcomes mentioned include symptom burden, distress, quality of life, alignment of care with patient goals, and hospitalization patterns.
What types of outcomes for family caregivers may be addressed under this FOA?
Examples of caregiver outcomes mentioned include caregiving burden, preparedness, communication experiences, satisfaction with care, and bereavement-related outcomes.
What types of transitions or disruptions is this FOA concerned with?
The FOA highlights unwanted or poorly managed transitions near the end of life, such as transfers between settings and disruptions in who is providing care. It is concerned with reducing distress and harm linked to these transitions and improving how transitions are handled when they are appropriate.
Who is eligible to apply for this NIH FOA?
Eligibility is broad and includes many public and private organizations, including state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (as long as they are not institutions of higher education); for-profit organizations other than small businesses; and small businesses.
Are organizations serving specific communities explicitly encouraged or included?
Yes. The FOA explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), and faith-based or community-based organizations.
Can federal agencies apply?
Yes. The FOA lists eligible federal agencies among the eligible applicant types.
Are U.S. territories or possessions included as eligible applicants?
Yes. The FOA includes U.S. territories or possessions among eligible applicant types.
Are foreign (non-U.S.) organizations eligible to apply?
Yes. The FOA includes non-U.S. (foreign) organizations among eligible applicant types.
Is there an award ceiling listed for this opportunity?
No award ceiling is specified in the provided details.
Are the expected number of awards listed?
No. Expected awards are not listed in the provided details, which is common for NIH program announcements where budgets can depend on scope, institute priorities, and availability of funds.
How is this opportunity categorized administratively?
It is described as a discretionary grant in the NIH system and categorized under education and health. The CFDA number provided is 93.361.
What are the posting and closing dates provided for PA 18-148?
The original posting date provided is November 7, 2017, and the original closing date listed is January 7, 2020. The description notes that NIH opportunities sometimes have multiple receipt dates or may be reissued over time, but the provided source data lists that closing date.
What is the overall intended impact of the research supported by this FOA?
The intended impact is stronger evidence on how to prevent avoidable, unwanted end-of-life transitions and how to build hospice care processes that remain consistent, coordinated, and person- and family-centered across settings. The FOA aims to improve clinical and quality-of-life outcomes for hospice patients and reduce stress while improving support for family caregivers.
Browse more opportunities from the same category: Education, Health
Next opportunity: Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R15 Clinical Trial Not Allowed)
Previous opportunity: Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 148
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 148) also looked into and applied for these:
| Funding Opportunity |
|---|
| Personalized Strategies to Manage Symptoms of Chronic Illness (R21 Clinical Trial Optional) Apply for PA 18 156 Funding Number: PA 18 156 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Innovative Questions in Symptom Science and Genomics (R01 Clinical Trial Optional) Apply for PA 18 139 Funding Number: PA 18 139 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Use of Technology to Enhance Patient Outcomes and Prevent Illness (R21 Clinical Trial Optional) Apply for PA 18 163 Funding Number: PA 18 163 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Addressing Unmet Needs in Persons with Dementia to Decrease Behavioral Symptoms and Improve Quality of Life (R21 Clinical Trial Optional) Apply for PA 18 165 Funding Number: PA 18 165 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional) Apply for PA 18 138 Funding Number: PA 18 138 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Apply for PA 18 159 Funding Number: PA 18 159 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R21 Clinical Trial Optional) Apply for PA 18 161 Funding Number: PA 18 161 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Health Promotion Among Racial and Ethnic Minority Males (R21 Clinical Trial Optional) Apply for PA 18 162 Funding Number: PA 18 162 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Use of Technology to Enhance Patient Outcomes and Prevent Illness (R01 Clinical Trial Optional) Apply for PA 18 145 Funding Number: PA 18 145 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R01 Clinical Trial Optional) Apply for PA 18 146 Funding Number: PA 18 146 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Symptom Management in HIV-Infected Individuals with Comorbid Conditions (R01 Clinical Trial Optional) Apply for PA 18 143 Funding Number: PA 18 143 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R21- Clinical Trial Not Allowed) Apply for RFA MH 18 611 Funding Number: RFA MH 18 611 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) Apply for PA 18 149 Funding Number: PA 18 149 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Questions in Symptom Science and Genomics (R21 Clinical Trial Optional) Apply for PA 18 157 Funding Number: PA 18 157 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Self-Management Interventions and Technologies to Sustain Health and Optimize Functional Capabilities (R21 Clinical Trial Optional) Apply for PA 18 164 Funding Number: PA 18 164 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) Apply for PA 18 167 Funding Number: PA 18 167 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional) Apply for PA 18 166 Funding Number: PA 18 166 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Short-term Mentored Career Enhancement Awards for Mid-Career Investigators to Integrate Basic Behavioral and Social Sciences (K18 - No Independent Clinical Trials) Apply for PAR 18 349 Funding Number: PAR 18 349 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Altered neuronal circuits, receptors and networks in HIV-induced Central Nervous System (CNS) dysfunction (R01)-Clinical Trial Not Allowed Apply for RFA MH 18 610 Funding Number: RFA MH 18 610 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Apply for PAR 18 008 Funding Number: PAR 18 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 148", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.